October 2023 FDA Recall Montelukast Sodium by Dr. Reddy's Laboratories, Inc.
D-0086-2024 - Presence of Foreign Tablet(s/Capsule(s

This Class II drug recall was voluntarily initiated by Dr. Reddy's Laboratories, Inc. on October 13, 2023 for the product Montelukast Sodium. The FDA reported the reason for recall as presence of foreign tablet(s)/capsule(s). The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0086-2024

Reason for Recall
Presence of Foreign Tablet(s)/Capsule(s): A foreign tablet was found in a bottle of Montelukast Sodium Tablets, USP 10mg, identified as metoprolol 25 mg.
Initiated
10-13-2023
Reported
11-15-2023
Quantity
1,656 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Dr. Reddy's Laboratories, Inc.
Montelukast Sodium Tablets, USP 10 mg, Rx Only, 1000 count bottle, Distributed by: Dr. Reddy's Laboratories., Princeton, NJ 08540, Made in India, NDC# 55111-725-10.

Batch or Lot Expiration Information

Lot# C2305569, Exp. date 03/31/2026